z-logo
open-access-imgOpen Access
Changes in genetic diversity of the Bordetella pertussis population in Serbia between 1953 and 2011
Author(s) -
Tatjana Pljesa,
Qiushui He,
Gordana Dakic,
Mirjana Vignjevic-Krastavcevic,
Nevenka Miković,
Ivana Ćirković
Publication year - 2014
Publication title -
archives of biological sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.217
H-Index - 25
eISSN - 1821-4339
pISSN - 0354-4664
DOI - 10.2298/abs1401107p
Subject(s) - pertactin , bordetella pertussis , genotype , biology , genotyping , serotype , population , vaccination , microbiology and biotechnology , virology , genetic diversity , allele , pertussis vaccine , pertussis toxin , genetics , immunization , immune system , medicine , gene , bacteria , receptor , environmental health , g protein
Mass vaccination has significantly reduced the incidence of pertussis, however, the disease is re-emerging, even in some countries with high vaccination coverage. In Serbia, whole cell pertussis vaccine was introduced in 1957. To moni- tor changes in bacterial population, 77 isolates collected from 1953 to 2011 were studied. The methods included serotyp- ing of fimbriae (Fim), genotyping of pertactin (prn) and pertussis toxin S1 subunit (ptxA). A shift from ptxA2 to ptxA1 has been observed in isolates since the late of 1960s. In the period 1961-1979, the genotype ptxA1 became as common as genotype ptxA2. After that, during the period 1980-1989, the predominant ptx genotype was ptxA1. The reappearance of the ptxA2 allele followed an addition of the two strains harboring ptxA1 in the vaccine in 1985. The allele prn1 was predominant among the Serbian isolates, though prn3 and prn11 have been detected since 1981. The prn2 allele was only found in one strain isolated in 1984, two of the four strains isolated in 2000 and in three isolated strains from 2011. Sero- type Fim2.3 disappeared before 1980 and serotype Fim2 became predominant thereafter. The results of this study indicate that the B. pertussis population in Serbia is different from other vaccinated populations and that this difference may be related to the vaccine used.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom